Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Ploemeur

3 clinical trials in Ploemeur, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Ploemeur at a glance
3
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

3 trials in Ploemeur

Open in trial search
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:E.coli Polysaccharide
  • Sponsor:Centre Hospitalier Universitaire De Dijon
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexmedetomidine
  • Sponsor:Centre Hospitalier Universitaire De Rennes
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Botulinum Toxin Type A
  • Sponsor:Ipsen Pharma

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Ploemeur

What the registry says about research in the country

01 Ploemeur
Analytical, Diagnostic and Therapeutic Techniques and Equipment – Anesthesia and Analgesia
In Ploemeur, investigators are evaluating innovative anaesthetic strategies to improve surgical outcomes. One recruiting study compares opioid‑free anaesthesia with standard opioid‑based protocols in video‑assisted thoracic surgery and robot‑assisted thoracic surgery, focusing on patient‑reported quality of recovery and safety. Evaluation of non‑opioid based anaesthetic regimens Assessment of peri‑operative safety and adverse event rates Patient‑centered recovery metrics after thoracic procedures Comparison of surgical techniques (VATS vs RATS) on anaesthetic outcomes These trials aim to identify safer, more comfortable anaesthesia practices, potentially shaping future standards in thoracic surgery across the region.
Diseases – Nervous System Diseases
The city also hosts a trial addressing upper limb spasticity of various origins. Researchers are comparing the efficacy and safety of Dysport® versus Botox® injections to determine non‑inferior outcomes based on adverse event profiles over twelve weeks. Direct head‑to‑head comparison of botulinum toxin products Monitoring of treatment‑emergent adverse events Impact on motor function and spasticity severity Patient‑reported outcomes on daily activity performance Findings could broaden therapeutic options for individuals living with spasticity and inform clinical guidelines for nervous system disorder management.
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.